NCT04328662 2026-03-04
A Study of Ninlaro in Real World Clinical Practice in China
Takeda
Completed
Clinical Trials
8 trialsNCT07354555 2026-01-21
MMExFFPE
BIWAKO
Not yet recruiting
NCT06504524 2025-06-27
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
Completed
NCT05932290 2024-10-29
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT05565391 2024-05-21
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT05032339 2023-10-30
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyricâ„¢ Flow Cytometer
Becton, Dickinson and Company
Completed
NCT02528838 2020-05-27
REVIEW
Celgene
Completed
NCT00195533 2009-11-16
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer
Completed